Albuminuria Regression in Diabetes: A Therapeutic Target for Nephro- and Cardio-Protection, in Clinics and Research

Piero Ruggenenti; Giuseppe Remuzzi

doi:10.1159/000496275

Back

Albuminuria Regression in Diabetes: A Therapeutic Target for Nephro- and Cardio-Protection, in Clinics and Research

Letter 2019 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2004

Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

Dick de Zeeuw, Giuseppe Remuzzi, Hans‐Henrik Parving, William F. Keane, Zhongxin Zhang, Shahnaz Shahinfar, Steve Snapinn, Mark E. Cooper, William E. Mitch, Barry M. Brenner

Article2005

Is Regression of Chronic Nephropathies a Therapeutic Target?

Giuseppe Remuzzi, Andrea Remuzzi

Article2024

Cardio-reno-vascular protection in type 2 diabetes mellitus: new insights into pharmacotherapeutic management

Oliwia Janota, Hanna Kwiendacz, Anna Olejarz, Aleksandra Włosowicz, Patrycja Pabis, Janusz Gumprecht, Uazman Alam, Professor Gregory Lip, Katarzyna Nabrdalik

Article2011

Sleep-Time Blood Pressure as a Therapeutic Target for Cardiovascular Risk Reduction in Type 2 Diabetes

Ramon C Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández

Article2014

Sleep-time blood pressure as a therapeutic target for reducing the risk of developing diabetes

Ramon C Hermida, Diana E. Ayala, Artemio Mojón, José R. Fernández